Olfactory neuroblastoma: The University of Erlangen-Nuremberg experience 1975-2000

Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 5, 2004, Pages 567-574

  Constantinidis, Jannis ^a,b   Steinhart, Helmut ^a   Koch, Michael ^a   Buchfelder, Michael ^a   Schaenzer, Anne ^a   Weidenbecher, Manfred ^a   Iro, Heinrich ^a  

^a University of Erlangen Nuremberg ^*

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; ESTHESIONEUROBLASTOMA; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; MALE; NOSE CAVITY TUMOR; PARANASAL SINUS TUMOR; PROGNOSIS; SALVAGE THERAPY; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR RECURRENCE;

EID: 2442695314     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2003.10.010     Document Type: Article

References (28)

1. Berger L, Luc R. L'esthesioneuroepitheliome olfactif. Bull Assoc Franc Etude Cancer 1924;13:410-21.
2. Broich I, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 1997;17:2683-706.
3. Olsen KD, DeSanto LW. Olfactory neuroblastoma: biologic and clinical behavior. Arch Otolaryngol 1983;109: 797-802.
4. Elkon D, Hightower SI, Lim ML, et al. Esthesioneuroblastoma. Cancer 1979;44:1087-94.
5. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma-long term outcome and patterns of failure-the University of Virginia experience. Cancer 1994;73:2556-62.
6. Levine PA, Gallagher R, Cantrell RW. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999;109:1539-43.
7. Resto VA, Eisele DW, Forastiere A, et al. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck 2000;55:550-8.
8. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976;37: 1571-6.
9. Morita A, Ebersold MJ, Olsen KD, et al. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993;32:706-15.
10. Biller HF, Lawson W, Sachdev VP, et al. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 1990;100:1199-201.
11. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992;102: 843-9.
12. Koka VN, Julieron M, Bourhis J, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998;112:628-33.
13. Hyams VJ. Tumors of the upper respiratory tract and ear. In: Hyams VJ, Batsakis JG, Michaels L, editors. Atlas of tumor pathology. Second series, fascicle 25. Washington (DC): Armed Forces Institute of Pathology; 1988. p. 240-8.
14. Miyamoto RC, Gleich LL, Biddinger PW, et al. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope 2000;110: 1262-5.
15. Eriksen JG, Basthold L, Krogdahl AS, et al. Esthesioneuroblastoma. What is the optimal treatment? Acta Oncol 2000;39:231-5.
16. Fahlbusch R, Neubauer U, Wigand M, et al. Neurorhinosurgical treatment of aesthesioneuroblastoma. Acta Neurochir 1989;100:93-100.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. th ed. Philadelphia: JB Lippincott Co; 1992. p. 11-23.
19. Spaulding CA, Kranyak MS, Constable WC, et al. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988;15:581-90.
20. Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998;42:1029-37.
21. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Rad Oncol 1993;27:835-42.
22. Strnad V, Grabenbauer GG, Dunst J, et al. Radiotherapie beim Ästhesioneuroblastom. Strahlenther Onkol 1994; 170:79-84.
23. Battacharyya N, Thornton AF, Joseph MP, et al. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Arch Otolaryngol Head Neck Surg 1997;123:34-40.
24. Walch C, Stammberger H, Anderhuber W, et al. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000;110:635-40.
25. Roux FX, Brasnu D, Villavicencio R, et al. Esthesioneuroblastomas: could a preoperative chemotherapy improve their prognosis? Neurochirurgie 1991;37:248-52.
26. McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery 1998;42:1023-8.
27. Stewart FM, Lazarus HM, Levine PA, et al. High-dose chemotherapy and autologous bone marrow transplantation for selected esthesioneroblastoma and sinonasal undiffentiated carcinoma. Am J Clin Oncol 1989;12:217-21.
28. Beitler JJ, Fass DE, Brenner HA, et al. Esthesioneuroblastoma: is there a role for elective neck treatment? Head Neck 1991;13:321-6.